This course will provide an overview of patient safety theory, the scope of medical errors, and new emerging guidelines and strategies to leverage patient safety concepts, reduce errors and improve patient safety.

This course will provide an introduction to the concept of risk management in healthcare settings, a historical perspective on the development of health care risk management, the role of the health care risk manager, and more.

This course examines the ways in which patients can accept responsibility for promoting good outcomes of the therapeutic modalities that the health care professionals and institutions provide.

This course is a continuation course that emphasizes the role of the legislative, executive and judicial branches of state and federal government in the establishment of standards for pharmacy practice and drug distribution.

This course challenges students to think about the development of public policy positions and the articulation of organizational policy positions.

This course emphasizes the role of the legislative, executive and judicial branches of state and federal government in the establishment of standards for pharmacy practice and drug distribution.

This course reviews federal Food and Drug Administration theory and practice, with a particular emphasis on product labeling requirements and the new drug approval process.

The Federal Controlled Substances Act, regulations promulgated by the Drug Enforcement Administration, and judicial interpretations of controversies in this area.

This course explores regulation intended to expand access to and control the costs of health care

This is an introduction to biomedical ethics primarily as applied to pharmaceutical and medical device products.

Facilitators will explore recent high-profile medical errors and their impact on the health care environment, and other timely topics.

Access to health care for the elderly and poor provided by Titles XVIII and XIX of the Federal Social Security Act.

This course describes the history of the FDA and CMS. Agency organization and responsibility is explained. Administrative practices and procedures are described, including formal and informal rule making. The course discusses the interaction of federal agencies with state regulators.

The purpose of this course is to introduce students to the fundamental methods of pharmacoeconomic analysis. The class will focus on the theory, methods, and application of technology assessment in health care. Applications will be drawn from a variety of health care settings.

This course is designed to analyze and explore the special features and complexities of health care markets. It will focus on the analysis of consumption, production, and distribution of health and health care services with an emphasis on pharmaceutical products and services.

This course will build on Pharmaceutical Microeconomics by delving into the economic principles and issues of health care in the US.

This course provides an overview of the False Claims Act, the Qui Tam action, and Stark Laws, within an overall framework of the prevention of fraud, abuse and waste in healthcare.

This course will focus on building the skills necessary to incorporate timely and rigorously analyzed medical and pharmacoeconomic literature into a rational decision making process.

This course will explore the methodologies through which patient safety data are collected and evaluated. The use of existing databases on patient safety will be examined.

This course provides an introduction to methods and techniques for conducting pharmacoeconomic studies.

This course will introduce students to basic epidemiology principles with a particular focus on how they are applied to pharmaceuticals.

This course builds on PHA6276 Pharmacy Benefit Design & Management and probes development and operational management of a managed care prescription drug benefit program.

This course introduces biostatistical concepts and methods used in pharmacy and medical literature.

The purpose of this course is an introduction to analyzing medical and pharmacy data using programming techniques in SAS and SQL.

This course is an introduction to intermediate and advanced methods of analyzing healthcare data by exposure to utilizing clinical risk adjustment models in SAS currently used in industry.